# a Phase III Trial of Safety and Efficacy of Premedication With Dexmedetomidine and Midazolam in Pediatric Patients

> **NCT04356638** · PHASE3 · UNKNOWN · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 80 (estimated)

## Conditions studied

- Anxiety State
- Perioperative/Postoperative Complications

## Interventions

- **DRUG:** Midazolam
- **DRUG:** Dexmedetomidine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04356638
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-17
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04356638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04356638, "a Phase III Trial of Safety and Efficacy of Premedication With Dexmedetomidine and Midazolam in Pediatric Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04356638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*